» Articles » PMID: 28296232

Inhibitors of Soluble Epoxide Hydrolase Minimize Ischemia-reperfusion-induced Cardiac Damage in Normal, Hypertensive, and Diabetic Rats

Overview
Journal Cardiovasc Ther
Publisher Hindawi
Date 2017 Mar 16
PMID 28296232
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: We designed a study to evaluate the cardioprotective effect of two soluble epoxide hydrolase (sEH) inhibitors, 1-(1-propanoylpiperidin-4-yl)-3-(4-trifluoromethoxy)phenyl)urea (TPPU) and trans-4-{4-[3-(4-trifluoromethoxyphenyl)-ureido]cyclohexyloxy}benzoic acid (t-TUCB), in ischemia-reperfusion (IR) model.

Methods: Cardioprotective effects of the sEH inhibitors were evaluated against IR-induced myocardial damage in hearts from normal, hypertensive, and diabetic rats using Langendorff's apparatus. In addition, the effect of sEH inhibitors on endothelial function was evaluated in vitro and ex vivo using isolated rat thoracic aorta.

Results: Ischemia-reperfusion (IR) increased the myocardial damage in hearts from normal rats. IR-induced myocardial damage was augmented in hearts isolated from hypertensive and diabetic rats. Myocardial damage as evident from increase in the activities of lactate dehydrogenase (LDH) and creatine kinase-MB (CK-MB) in heart perfusate was associated with significant decrease in the heart rate and developed tension, and increase in the resting tension in isolated heart. Both sEH inhibitors protected the heart in normal, hypertensive, and diabetic rats subjected to IR injury. The sEH inhibitor t-TUCB relaxed phenylephrine precontracted aorta from normal rats. Relaxant effect of acetylcholine (ACh) was reduced in aortas from diabetic and hypertensive rats compared to normal rats. Pretreatment of sEH inhibitors to diabetic and hypertensive rats increased relaxant effect of ACh on aortas isolated from these rats.

Conclusions: Prophylactic treatment with sEH inhibitors decreased myocardial damage due to IR, hypertension and diabetes, and decreased endothelial dysfunction created by diabetes and hypertension. Therefore, inhibitors of sEH are useful probes to study cardiovascular pathology, and inhibition of the sEH is a potential approach in the management of IR-induced cardiac damage and endothelial dysfunction-related cardiovascular disorders.

Citing Articles

The role of CYP-sEH derived lipid mediators in regulating mitochondrial biology and cellular senescence: implications for the aging heart.

Yousef A, Fang L, Heidari M, Kranrod J, Seubert J Front Pharmacol. 2024; 15:1486717.

PMID: 39703395 PMC: 11655241. DOI: 10.3389/fphar.2024.1486717.


Inhibition of Soluble Epoxide Hydrolase Ameliorates Cerebral Blood Flow Autoregulation and Cognition in Alzheimer's Disease and Diabetes-Related Dementia Rat Models.

Tang C, Border J, Zhang H, Gregory A, Bai S, Fang X bioRxiv. 2024; .

PMID: 39257786 PMC: 11383657. DOI: 10.1101/2024.08.30.610540.


Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine .

Zou L, Zhao F, Qi Y, Wang S, Zhou Q, Geng P Front Pharmacol. 2023; 14:1186824.

PMID: 37288113 PMC: 10242136. DOI: 10.3389/fphar.2023.1186824.


Exploration of the Mechanism of Linoleic Acid Metabolism Dysregulation in Metabolic Syndrome.

Wen Y, Shang Y, Wang Q Genet Res (Camb). 2022; 2022:6793346.

PMID: 36518097 PMC: 9722286. DOI: 10.1155/2022/6793346.


Targeting IRE1α-JNK-c-Jun/AP-1-sEH Signaling Pathway Improves Myocardial and Coronary Endothelial Function Following Global Myocardial Ischemia/Reperfusion.

Xue H, Sun W, Chen H, He G, Yang Q Int J Med Sci. 2022; 19(9):1460-1472.

PMID: 36035373 PMC: 9413556. DOI: 10.7150/ijms.74533.


References
1.
Harris T, Bettaieb A, Kodani S, Dong H, Myers R, Chiamvimonvat N . Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice. Toxicol Appl Pharmacol. 2015; 286(2):102-11. PMC: 4458210. DOI: 10.1016/j.taap.2015.03.022. View

2.
Imig J, Zhao X, Zaharis C, Olearczyk J, Pollock D, Newman J . An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension. 2005; 46(4):975-81. PMC: 1444888. DOI: 10.1161/01.HYP.0000176237.74820.75. View

3.
Weber K, Janicki J . The metabolic demand and oxygen supply of the heart: physiologic and clinical considerations. Am J Cardiol. 1979; 44(4):722-9. DOI: 10.1016/0002-9149(79)90294-7. View

4.
Bai S, Cheng L, Yang Y, Fan C, Zhao D, Qin Z . C1q/TNF-Related Protein 9 Protects Diabetic Rat Heart against Ischemia Reperfusion Injury: Role of Endoplasmic Reticulum Stress. Oxid Med Cell Longev. 2016; 2016:1902025. PMC: 5067328. DOI: 10.1155/2016/1902025. View

5.
Ewing D, Campbell I, CLARKE B . Heart rate changes in diabetes mellitus. Lancet. 1981; 1(8213):183-6. DOI: 10.1016/s0140-6736(81)90061-1. View